Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Nimitphong, Hataikarn ^a   Saetung, Sunee ^a   Chanprasertyotin, Suwannee ^a   Chailurkit, La Or ^a   Ongphiphadhanakul, Boonsong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

25 hydroxyvitamin D; Vitamin D binding protein(DBP); Vitamin D2; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; REAL TIME POLYMERASE CHAIN REACTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; CALCIUM, DIETARY; CHOLECALCIFEROL; CHROMATOGRAPHY, LIQUID; DIETARY SUPPLEMENTS; ERGOCALCIFEROLS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 84875688664     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-39     Document Type: Article

References (23)

1. Institute of Medicine, Dietary Reference Intakes for Calcium and Vitamin D Washington, DC: National Academy of Sciences 2011
2. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, J Clin Endocrinol Metab 96 7 1911 1930
3. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG, J Clin Endocrinol Metab 1986 63 4 954 959 10.1210/jcem-63-4-954 3745408
4. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J, Am J Clin Nutr 2009 89 2 634 640 10.3945/ajcn.2008.26445 19116321
5. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, Nexo E, Calcif Tissue Int 2005 77 1 15 22 10.1007/s00223-004-0227-5 15868280
6. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM, J Clin Endocrinol Metab 2008 93 9 3381 3388 10.1210/jc.2007-2702 18593774
7. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Fu L, Yun F, Oczak M, Wong BY, Vieth R, Cole DE, Clin Biochem 2009 42 10-11 1174 1177 19302999
8. Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets. Thacher TD, Fischer PR, Obadofin MO, Levine MA, Singh RJ, Pettifor JM, J Bone Miner Res 25 9 1988 1995
9. Vitamin D2 is much less effective than vitamin D3 in humans. Armas LA, Hollis BW, Heaney RP, J Clin Endocrinol Metab 2004 89 11 5387 5391 10.1210/jc.2004-0360 15531486
10. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD, Bone 2009 45 5 870 875 10.1016/j.bone.2009.07.015 19631774
11. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD, J Clin Endocrinol Metab 2008 93 3 677 681 18089691
12. Vitamin D(3) is more potent than vitamin D(2) in humans. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA, J Clin Endocrinol Metab 96 3 447 452
13. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, Chope G, Hypponen E, Berry J, Vieth R, Am J Clin Nutr 95 6 1357 1364
14. Treatment with 50,000 IU vitamin D(2) every other week and effect on serum 25-hydroxyvitamin D(2), 25-hydroxyvitamin D(3), and total 25-hydroxyvitamin D in a clinical setting. Demetriou ET, Travison TG, Holick MF, Endocr Pract 18 3 399 402
15. Decreased bioavailability of vitamin D in obesity. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF, Am J Clin Nutr 2000 72 3 690 693 10966885
16. Type of dietary fat is associated with the 25-hydroxyvitamin D3 increment in response to vitamin D supplementation. Niramitmahapanya S, Harris SS, Dawson-Hughes B, J Clin Endocrinol Metab 96 10 3170 3174
17. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Farraye FA, Nimitphong H, Stucchi A, Dendrinos K, Boulanger AB, Vijjeswarapu A, Tanennbaum A, Biancuzzo R, Chen TC, Holick MF, Inflamm Bowel Dis 17 10 2116 2121
18. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Speeckaert M, Huang G, Delanghe JR, Taes YE, Clin Chim Acta 2006 372 1-2 33 42 16697362
19. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, Cooke NE, J Clin Invest 1999 103 2 239 251 10.1172/JCI5244 9916136
20. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. Hollis BW, J Steroid Biochem 1984 21 1 81 86 10.1016/0022-4731(84)90063-3 6087030
21. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Sathyapalan T, Shepherd J, Arnett C, Coady AM, Kilpatrick ES, Atkin SL, Clin Chem 56 11 1696 1700
22. STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D. Ertugrul DT, Yavuz B, Cil H, Ata N, Akin KO, Kucukazman M, Yalcin AA, Dal K, Yavuz BB, Tutal E, Cardiovasc Ther
23. Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER. Goldstein MR, Mascitelli L, Pezzetta F, Int J Cardiol 145 3 556 557